Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Mariam Alatrach"'
Autor:
Anthony H. Cincotta, Eugenio Cersosimo, Mariam Alatrach, Michael Ezrokhi, Christina Agyin, John Adams, Robert Chilton, Curtis Triplitt, Bindu Chamarthi, Nicholas Cominos, Ralph A. DeFronzo
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 16, p 8851 (2022)
Bromocriptine-QR is a sympatholytic dopamine D2 agonist for the treatment of type 2 diabetes that has demonstrated rapid (within 1 year) substantial reductions in adverse cardiovascular events in this population by as yet incompletely delineated mech
Externí odkaz:
https://doaj.org/article/a12bfaed54a74d00bcefdb4e1daeb71c
Autor:
Mohamed Abu‐Farha, Mariam Alatrach, Jehad Abubaker, Irina Al‐Khairi, Preethi Cherian, Krisitn Agyin, Siham Abdelgani, Luke Norton, John Adams, Dalal Al‐Saeed, Ebaa Al‐Ozairi, Ralph A DeFronzo, null Fahd Al‐Mulla, Muhammad Abdul‐Ghani
Publikováno v:
Diabetes/Metabolism Research and Reviews.
Autor:
null Olga Lavynenko, null Muhammad Abdul‐Ghani, null Mariam Alatrach, null Curtiss Puckett, null John Adams, null Siham Abdelgani, null Naim Alkhouri, null Curtis Triplitt, null Geoffrey D. Clarke, null Juan A. Vasquez, null Jinqi Li, null Eugenio Cersosimo, null Amalia Gastaldelli, null Ralph A. DeFronzo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc78a059271b849b6ffbc6960f564e98
https://doi.org/10.1111/dom.14650/v3/response1
https://doi.org/10.1111/dom.14650/v3/response1
Autor:
Olga Lavynenko, Muhammad Abdul‐Ghani, Mariam Alatrach, Curtiss Puckett, John Adams, Siham Abdelgani, Naim Alkhouri, Curtis Triplitt, Geoffrey D. Clarke, Juan A. Vasquez, Jinqi Li, Eugenio Cersosimo, Amalia Gastaldelli, Ralph A. DeFronzo
Publikováno v:
Diabetes, obesitymetabolismREFERENCES. 24(5)
To compare the efficacy of triple therapy (metformin/exenatide/pioglitazone) versus stepwise conventional therapy (metformin → glipizide → glargine insulin) on liver fat content and hepatic fibrosis in newly diagnosed, drug-naïve patients with t
Autor:
John Adams, Muhammad A. Abdul-Ghani, Ali M. Ali, Curtis L Triplitt, Mariam Alatrach, Nitchakarn Laichuthai, Ralph A. DeFronzo, Olga Lavynenko, Robert A. Martinez, Hussein Al-Jobori, Christina Agyin, Eugenio Cersosimo
Publikováno v:
Diabetes
Sodium–glucose cotransport 2 inhibitors (SGLT2i) lower plasma glucose but stimulate endogenous glucose production (EGP). The current study examined the effect of dapagliflozin on EGP while clamping plasma glucose, insulin, and glucagon concentratio
Autor:
Mariam Alatrach, Christina Agyin, Carolina Solis-Herrera, Olga Lavryneko, John Adams, Amalia Gastaldelli, Curtis Triplitt, Ralph A. DeFronzo, Eugenio Cersosimo
Publikováno v:
Diabetes Care
OBJECTIVE To examine the effect of SGLT2 inhibitors (SGLT2i) on endogenous glucose production (EGP) in patients with type 2 diabetes after an oral glucose load. RESEARCH DESIGN AND METHODS Forty-eight patients with type 2 diabetes received an 8-h [3-
Autor:
Nicholas Cominos, Ralph A. DeFronzo, John Adams, Curtis L Triplitt, Michael Ezrokhi, Anthony H. Cincotta, Eugenio Cersosimo, Christina Agyin, Mariam Alatrach
Publikováno v:
Diabetes. 70
Background: Both CNS reduced dopaminergic and elevated sympathetic tone converge to stimulate a POS/PI phenotype that promotes cardiovascular disease (CVD) and augments postprandial hyperglycemia in T2DM. BQR, a sympatholytic dopamine agonist for tre
Autor:
John Adams, Michael Ezrokhi, Mariam Alatrach, Ralph A. DeFronzo, Christina Agyin, Curtis L Triplitt, Eugenio Cersosimo, Nicholas Cominos, Anthony H. Cincotta
Publikováno v:
Diabetes. 69
Background: Elevated sympathetic tone stimulates a POS/PI leucocyte phenotype that promotes cardiovascular disease (CVD) and augments postprandial hyperglycemia in T2D. BQR, a sympatholytic dopamine agonist for treatment of T2DM, improves postprandia
Autor:
Eugenio Cersosimo, John Adams, Ralph A. DeFronzo, Olga Lavrynenko, Juan A. Vasquez, Geoffrey D. Clarke, Naim Alkhouri, Muhammad A. Abdul-Ghani, Curtiss L. Puckett, Mariam Alatrach
Publikováno v:
Diabetes. 69
Patients with NAFLD and T2DM are at high risk of liver fibrosis. Pioglitazone(Pio) and GLP-1RAs have shown efficacy against NAFLD. The EDICT trial assessed Triple (pio/exenatide/metformin(met)) vs. Conventional(Conv) (met/SU/insulin) Therapy. Aim: Ev
Autor:
John Adams, Curtis L Triplitt, Eugenio Cersosimo, Mariam Alatrach, Christina Agyin, Olga Lavrynenko, Nitchakarn Laichuthai, Muhammad A. Abdul-Ghani, Ralph A. DeFronzo
Publikováno v:
Diabetes. 69
Aim: To examine the effect of SGLT2i on endogenous glucose production (EGP), tissue glucose disappearance (Rd), and urinary glucose excretion (UGE) following glucose ingestion. Study Design: 28 type 2 diabetes [T2D] patients (Age= 51±2 y; BMI=31.2±